Studying TIGIT activity against tumors through the generation of knockout mice-Reference-Cited by-同舟云学术

Studying TIGIT activity against tumors through the generation of knockout mice

Published:2023-05-29 Issue:1 Volume:12 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Rishiq Ahmed¹,Bsoul Reem²,Pick Ophir¹,Mandelboim Ofer¹

Affiliation:

1. The Concern Foundation Laboratories at the Lautenberg Center for Immunology and Cancer Research, Institute for Medical Research Israel Canada (IMRIC), Hebrew University-Hadassah Medical School, Jerusalem, Israel

2. The Institute of Dental Sciences, The Hebrew University-Hadassah School of Dental Medicine, Jerusalem, Israel

Funder

the Israel Innovation Authority Kamin grant

the German-Israeli Foundation for Scientific Research and Development grant

the Israel Science Foundation Moked grant

the Ministry of Science and Technology grant

the ICRF professorship grant, the ISF Israel–China grant

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2023.2217735

Reference36 articles.

1. Inhibitory and Coactivating Receptors Recognising the Same Ligand: Immune Homeostasis Exploited by Pathogens and Tumours

2. Immunotherapy for cancer treatment

3. Combination of CTLA-4 and PD-1 blockers for treatment of cancer

4. Immune checkpoint inhibitors in cancer therapy: a focus on T-regulatory cells

5. TIGIT: A Key Inhibitor of the Cancer Immunity Cycle

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing immunity against Candida albicans infections through TIGIT knockout;mBio;2024-09-11

2. Immune-checkpoint inhibitor-mediated myocarditis: CTLA4, PD1 and LAG3 in the heart;Nature Reviews Cancer;2024-07-09

3. The World of Immunotherapy Needs More Than PD-1/PD-L1—Two of the New Kids on the Block: LAG-3 and TIGIT;Onco;2024-07-01

4. Deciphering the role of alternative splicing in neoplastic diseases for immune-oncological therapies;Frontiers in Immunology;2024-04-26

5. Single-cell RNA sequencing unveils tumor heterogeneity and immune microenvironment between subungual and plantar melanoma;Scientific Reports;2024-03-25